| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |